The use of magnesium sulfate can reduce the mortality risk of cirrhosis patients: a retrospective cohort study
Magnesium sulfate use is associated with reduced in-hospital and 180-day all-cause mortality in ICU patients with cirrhosis, which needs to be verified in prospective studies.
Authors
- Yuping Yang (ORCID: https://orcid.org/0000-0001-5597-1881)
- Jieming Zheng
- Shicai Ye (ORCID: https://orcid.org/0009-0005-7663-7379)
- Mingkai Liang (ORCID: https://orcid.org/0009-0007-4370-6838)
- Bo Chen (ORCID: https://orcid.org/0000-0003-3750-2533)
- Liping Zhan
- Yujie Huang (ORCID: https://orcid.org/0009-0000-9932-7473)
- Qing Zhang (ORCID: https://orcid.org/0000-0001-5190-7751)
- Zhe Huang (ORCID: https://orcid.org/0009-0007-6634-0170)
- Hua‐Chih Huang
- Ruyin Ye
- Yanqi Kou (ORCID: https://orcid.org/0000-0001-8456-7474)
Institutions
- Guangdong Medical College (CN)
- Affiliated Hospital of Guangdong Medical College Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fphar.2025.1551495
- Primary Topic
- Magnesium in Health and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00